肌苷
核苷
药理学
抗惊厥药
腺苷
鸟苷
尿苷
癫痫
腺苷酸
医学
化学
腺苷受体
生物化学
受体
内科学
兴奋剂
精神科
基因
核糖核酸
作者
Zsolt Kovács,Katalin A. Kékesi,Gábor Juhász,János Barna,László Héja,Renáta Krisztina Lakatos,Árpád Dobolyi
标识
DOI:10.2174/1389557514666141107120226
摘要
Adenosine (Ado) and some non-adenosine (non-Ado) nucleosides including inosine (Ino), guanosine (Guo) and uridine (Urd) are modulatory molecules in the central nervous system (CNS), regulating different physiological and pathophysiological processes in the brain such as sleep and epilepsy. Indeed, different drugs effective on adenosinergic system (e.g., Ado metabolism inhibitors, agonists and antagonists of Ado receptors) are being used in drug development for the treatment of epileptic disorders. Although (i) endogenous Ino, Guo and Urd showed anticonvulsant/antiepileptic effects (e.g., in quinolinic acid - induced seizures and in different epilepsy models such as hippocampal kindling models), and (ii) there is a need to generate new and more effective antiepileptic drugs for the treatment of drug-resistant epilepsies, our knowledge about antiepileptic influence of non-Ado nucleosides is far from complete. Thus, in this review article, we give a short summary of anticonvulsant/antiepileptic effects and mechanisms evoked by Ino, Guo, and Urd. Finally, we discuss some non-Ado nucleoside derivatives and their structures, which may be candidates as potential antiepileptic agents. Keywords: Epilepsy, guanosine, inosine, uridine.
科研通智能强力驱动
Strongly Powered by AbleSci AI